About Macrodeep
New report 2026 AI SDR market benchmark: six platforms, eight workflow stages See the results →

The Report

Verified funding, headquarters, and leadership news from the world's most innovative businesses

117 reports and counting

Updated daily with latest market intelligence
Fundraising
Mironid

Mironid Raises $46M Series B for Polycystic Kidney Disease Drug

Mironid raised a $46 million Series B supported by the Scottish National Investment Bank and existing investors to advance clinical development of its ADPKD treatment.

SalesTools Research
Aug 5, 2026
2 min read•$46M
Fundraising
Rege Nephro

Rege Nephro Raises ~$10.6M in J-KISS Financing to Advance RN-014 and RN-032

Rege Nephro closed approximately $10.6 million through J-KISS share acquisition rights from 13 investors to advance RN-014 and RN-032 for kidney disease.

SalesTools Research
Jul 21, 2026
2 min read•~$10.6M
Fundraising
Diagonal Therapeutics

Diagonal Therapeutics Raises $125M Series B | Antibody Therapeutics

Biotech startup Diagonal Therapeutics secures $125 million Series B for rare genetic disease treatments.

SalesTools Research
Jan 7, 2026
0 min read•$125M
HealthTech
Strive

Strive raises $150M Series B

Strive raises $150M in Series B. Value-based care platform for kidney disease management...

Editorial Team
Aug 10, 2025
0 min read•$150M
HealthTech
Strive Health

Strive Health raises $550M Series D at $2.5B valuation

Strive Health raises $550M in Series D at $2.5B valuation. Care provider for kidney disease patients with value-based model...

Editorial Team
Sep 22, 2025
0 min read•$550M
HealthTech
Strive Health

Strive Health raises $300M Series D

Strive Health raises $300M in Series D. Value-based care provider for patients with kidney disease, includes $250M debt financing...

Editorial Team
Sep 12, 2025
0 min read•$300M
Biotech
Orna Therapeutics

Orna Therapeutics Raises $251M Series B

Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases

Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Azafaros

Azafaros Raises $146M Series B to Transform Biotech

Azafaros has secured $146M Series B in funding to accelerate growth and innovation in the biotech sector. Specialty pharmaceutical company advancing nizubaglustat for Gaucher disease and Parkinson's disease...

Emma Rodriguez
Oct 22, 2025
0 min read•$146M Series B
Pharmaceutical
Biogen Inc

Biogen Inc Headquarters - Office Location & Address

Discover Biogen Inc's headquarters at 225 Binney St, Cambridge, MA 02142. Biotechnology company pioneering science to deliver innovative medicines for neurodegenerative and rare diseases. Leader in multiple sclerosis treatments and Alzheimer's disease research with Aduhelm approval.. Learn about the office facilities and work environment.

Editorial Team
Oct 6, 2025
0 min read
Page 1

Showing 9 reports • Page 1 • Category: all

Stay ahead of the market

Get weekly insights delivered to your inbox. No spam, just intelligence.